[CAS NO. 2365241-79-6]  PI4KIIIbeta-IN-11

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [2365241-79-6]

Catalog
HY-148075
Brand
MCE
CAS
2365241-79-6

DESCRIPTION [2365241-79-6]

Overview

MDL-
Molecular Weight581.71
Molecular FormulaC33H39N7O3
SMILESCN1C(C2=CC=CC(CNC3=CC(C(C)(O)C)=NC4=C(C5=CC(C(N(C)[C@@H](C)CO)=O)=C(C=C5)C)C(C)=NN34)=C2)=NC=C1

For research use only. We do not sell to patients.

Summary

PI4KIIIbeta-IN-11 is an inhibitor of PI4KIIIβ , with a mean pIC 50 value of at least 9.1. PI4KIIIβ plays a key role in diseases research of RNA viruses and Plasmodium falciparum [1] [2] .


IC50 & Target

PI4KIIIβ

9.1 (pIC 50 )


In Vitro

PI4KIIIβ may be a relevant target protein for inhibition of Hedgehog signaling, and regulates trafficking from the Golgi system to the plasma membrane [1] .
PI4KIIIbeta-IN-11 (compound 22) (0.5 μM; 0-45 min) shows metabolic stability in human microsomes, with the intrinsic clearance of 33.7 mL/min/g [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

PI4KIIIbeta-IN-11 (compound 22) (1 mg/kg; i.v.; last over 1 h) displays a low spleen concentration in rats [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Wistar Han Rats [2]
Dosage: 1 mg/kg
Administration: Intravenous injection, formulated in 2% DMSO in Kleptose (aq, 10% w/v); over 1 hour; euthanised at 12 h
Result: Showed a low concentration in spleen of 5.54 ng/g.

Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Please store the product under the recommended conditions in the Certificate of Analysis.